Skip to main content
Log in

Neuropeptides and Nerve Growth in Inflammatory Bowel Diseases: A Quantitative Immunohistochemical Study

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Many studies have indicated changes in neuropeptides in inflammatory bowel disease (IBD), but with contradictory results. Nerve growth factor also has a potential role in the maintenance of enteric nerves and may be associated with IBD. A quantitative immunohistochemical method was used to measure area density of immunoreactive nerves in the colonic mucosa of surgical specimens. No significant differences in immunoreactivity for substance P, vasoactive intestinal polypeptide, growth associated protein 43, and the neurotrophin receptor p75 were seen in the control, Crohn's, and ulcerative colitis groups. Compared to age-matched normal colon (N = 18), there was an increase in neutrophil number in Crohn's (P < 0.05) and ulcerative colitis (P < 0.01) (both N = 9). There were positive correlations (P < 0.05) between neutrophil number and growth associated protein, between p75 and substance P immunoreactive nerves in ulcerative colitis, and between p75 and vasoactive intestinal polypeptide in Crohn's specimens. These data indicate a link between the immunologic and nervous systems in IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Collins SM: The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 111:1683–1699, 1996

    Google Scholar 

  2. Keranen U, Kiviluoto T, Jarvinen H, Back N, Kivilaakso E, Soinila S: Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis. Dig Dis Sci 40:2250–2258, 1995

    Google Scholar 

  3. Holzer P: Implications of tachykinins and calcitonin generelated peptide in inflammatory bowel disease. Digestion 59:269–283, 1998

    Google Scholar 

  4. Fairclouge PD, Bloom SR, Mitchell SJ: Plasma-VIP in ulcerative colitis. Lancet 1:964, 1976

    Google Scholar 

  5. Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S: Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology 79:853–860, 1980

    Google Scholar 

  6. Sjolund K, Schaffalitzky OB, Muckadell DE, Fahrenkrug J, Hakanson R, Peterson BG, Sundler F: Peptide-containing nerve fibres in the gut wall in Crohn's disease. Gut 24:724–733, 1983

    Google Scholar 

  7. O'Morain C, Bishop AE, McGregor GP, Levi AJ, Bloom SR, Polak JM, Peters TJ: Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. Gut 25:57–61, 1984

    Google Scholar 

  8. Koch TR, Carney JA, Go VL: Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 32:369–376, 1987

    Google Scholar 

  9. Duffy LC, Zielezny MA, Riepenhoff-Talty M, Byers TE, Marshall J, Weiser MM, Graham S, Ogra PL: Vasoactive intestinal peptide as a laboratory supplement to clinical activity index in inflammatory bowel disease. Dig Dis Sci 34:1528–1535, 1989

    Google Scholar 

  10. Goldin E, Karmeli F, Selinger Z, Rachmilewitz D: Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 34:754–757, 1989

    Google Scholar 

  11. Koch TR, Michener SR, Go VL: Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea. Gastroenterology 100:99–106, 1991

    Google Scholar 

  12. Mazumdar S, Das KM: Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. Am J Gastroenterol 87:176–181, 1992

    Google Scholar 

  13. Bernstein CN, Robert ME, Eysselein VK: Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Am J Gastroenterol 88:908–913, 1993

    Google Scholar 

  14. Besterman HS, Mallinson CN, Modigliani R, Christofides ND, Pera CA, Ponti V, Sarson DL, Bloom SR: Gut hormones in inflammatory bowel disease. Scand J Gastroenterol 18:845–852, 1993

    Google Scholar 

  15. Surrenti C, Renzi D, Garcea MR, Surreni E, Salvadori G: Colonic vasoactive intestinal polypeptide in ulcerative colitis. J Physiol (London) 87:307–311, 1993

    Google Scholar 

  16. Todorovic V, Janic B, Koko V, Micev M, Nikolic JA, Ratkovic M, Leposavic G, Jankovic T, Knezevic-Usaj S, Milicevic Z: Colonic vasoactive intestinal polypeptide(VIP) in ulcerative colitis—a radioimmunoassay and immunohistochemical study. Hepatogastroenterology 43:483–488, 1996

    Google Scholar 

  17. Yamamoto H, Morise K, Kusugami K, Furusawa A, Konagaya T, Nishio Y, Kaneko H, Uchida K, Nagai H, Mitsuma T, Nagura H: Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease. J Gastroenterol 31:525–532, 1996

    Google Scholar 

  18. Watanabe T, Kubota Y, Muto T: Substance P containing nerve fibers in rectal mucosa of ulcerative colitis. Dis Colon Rectum 40:718–725, 1997

    Google Scholar 

  19. Renzi D, Mantellini P, Calabro A, Panerai C, Amorosi A, Paladini E, Salvadori G, Garcea MR, Surrenti C: Substance P and vasoactive intestinal polypeptide but not calcitonin generelated peptide concentrations are reduced in patients with moderate and severe ulcerative colitis. Ital J Gastroenterol Hepatol 30:62–70, 1998

    Google Scholar 

  20. Watanabe T, Kubota Y, Muto T: Substance P containing nerve fibers in ulcerative colitis. Int J Colorectal Dis 13:61–67, 1998

    Google Scholar 

  21. Heuss D, Schlotzer-Schrehardt U: Subcellular localization of phosphoprotein B-50 in regenerating muscle. An immunoelectron microscopic study. Neurol Res 20:360–364, 1988

    Google Scholar 

  22. Li Y, Jiang N, Power C, Chopp M: Neuronal damage and plasticity identified by microtubule-associate protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke 29:1972–1981, 1998

    Google Scholar 

  23. Di Sebastiano P, Fink T, Di Mola FF, Weihe E, Innocenti P, Friess H, Buchler MW: Neuroimmune appendicitis. Lancet 354:462–466, 1999

    Google Scholar 

  24. Kobayashi H, Yamataka A, Fujimoto T, Lane GJ, Miyano T: Mast cells and gut nerve development: Implications for Hirschsprung's disease and intestinal neuronal dysplasia. J Pediatr Surg 34:543–548, 1999

    Google Scholar 

  25. Chao MV, Hempstead BL: p75 and Trk: A two-receptor system. Trends Neurosci 18:321–326, 1995

    Google Scholar 

  26. Woolf CJ, Ma Q, Allchorne A, Poole S: Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 16:2716–2723, 1996

    Google Scholar 

  27. Di Mola FF, Friess H, Zhu ZW, Koliopanos A, Bley T, Di Sebastiano P, Innocenti P, Zimmermann A, Buchler MW: Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut 46:670–679, 2000

    Google Scholar 

  28. Mantyh CR, Gates TS, Zimmerman RP, Welton ML, Edward PP, Vigna SR, Maggio JE, Kruger L, Mantyh PW: Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lynph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 85:3235–3239, 1988

    Google Scholar 

  29. Mantyh PW, Catton MD, Boehmer CG, Welton ML, Passaro EP, Maggio JE, Vigna R: Receptors for sensory neuropeptides in human inflammatory diseases: Implications for the effector role of sensory neurons. Peptides 10:627–645, 1989

    Google Scholar 

  30. Mantyh CR, Vigna SR, Bollinger RR, Manth PW, Maggio JE, Pappas TN: Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology 109:850–860, 1995

    Google Scholar 

  31. Lindsay RM, Lockett C, Sternberg J, Winter J: Neuropeptide expression in cultures of adult sensory neurons: Modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor. Neuroscience 33:53–65, 1989

    Google Scholar 

  32. Saldanha G, Hongo J, Plant G, Acheson J, Levy I, Anand P: Decreased CGRP, but preserved TrkA immunoreactivity in nerve fibres in inflamed human superficial temporal arteries. J Neurol Neurosurg 66:390–392, 1999

    Google Scholar 

  33. Gershon MD: V. Genes, lineages, and tissue interactions in the development of the enteric nervous system. Am J Physiol 275:G869–G873, 1998

    Google Scholar 

  34. Porter AJ, Wattchow DA, Brookes SJH, Costa M: Projections of nitric oxide synthase and vasoactive intestinal polypeptide-reactive submucosal neurons in the human colon. J Gastroenterol Hepatol 14:1180–1187, 1999

    Google Scholar 

  35. Horsch D, Kirsch JJ, Weihe E: Elevated density and plasticity of nerve fibres in anal fissures. Int J Colorectal Dis 13:134–140, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, C., Kumar, R., Lubowski, D. et al. Neuropeptides and Nerve Growth in Inflammatory Bowel Diseases: A Quantitative Immunohistochemical Study. Dig Dis Sci 47, 495–502 (2002). https://doi.org/10.1023/A:1017943430627

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1017943430627

Navigation